GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922) » Definitions » Cash-to-Debt

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Cash-to-Debt : 1.05 (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Cryofocus Medtech (Shanghai) Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Cryofocus Medtech (Shanghai) Co's cash to debt ratio for the quarter that ended in Dec. 2024 was 1.05.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Cryofocus Medtech (Shanghai) Co could pay off its debt using the cash in hand for the quarter that ended in Dec. 2024.

The historical rank and industry rank for Cryofocus Medtech (Shanghai) Co's Cash-to-Debt or its related term are showing as below:

HKSE:06922' s Cash-to-Debt Range Over the Past 10 Years
Min: 1.05   Med: 17.54   Max: 57.21
Current: 1.05

During the past 5 years, Cryofocus Medtech (Shanghai) Co's highest Cash to Debt Ratio was 57.21. The lowest was 1.05. And the median was 17.54.

HKSE:06922's Cash-to-Debt is ranked worse than
58.55% of 854 companies
in the Medical Devices & Instruments industry
Industry Median: 1.685 vs HKSE:06922: 1.05

Cryofocus Medtech (Shanghai) Co Cash-to-Debt Historical Data

The historical data trend for Cryofocus Medtech (Shanghai) Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Cryofocus Medtech (Shanghai) Co Cash-to-Debt Chart

Cryofocus Medtech (Shanghai) Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Cash-to-Debt
57.21 17.54 19.91 9.39 1.05

Cryofocus Medtech (Shanghai) Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cash-to-Debt Get a 7-Day Free Trial 19.91 15.85 9.39 1.85 1.05

Competitive Comparison of Cryofocus Medtech (Shanghai) Co's Cash-to-Debt

For the Medical Devices subindustry, Cryofocus Medtech (Shanghai) Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cryofocus Medtech (Shanghai) Co's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cryofocus Medtech (Shanghai) Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Cryofocus Medtech (Shanghai) Co's Cash-to-Debt falls into.


;
;

Cryofocus Medtech (Shanghai) Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Cryofocus Medtech (Shanghai) Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2024 is calculated as:

Cash to Debt Ratio= Cash, Cash Equivalents, Marketable Securities / Total Debt
= Cash, Cash Equivalents, Marketable Securities / (Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation)
=48.534 / (38.013 + 8.242)
=1.05

Cryofocus Medtech (Shanghai) Co's Cash to Debt Ratio for the quarter that ended in Dec. 2024 is calculated as:

Cash to Debt Ratio= Cash, Cash Equivalents, Marketable Securities / Total Debt
= Cash, Cash Equivalents, Marketable Securities / (Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation)
=48.534 / (38.013 + 8.242)
=1.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cryofocus Medtech (Shanghai) Co  (HKSE:06922) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Cryofocus Medtech (Shanghai) Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Cryofocus Medtech (Shanghai) Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Cryofocus Medtech (Shanghai) Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922) » Definitions » Cash-to-Debt
Comparable Companies
HKSE:02500 HKSE:02216 HKSE:02407 HKSE:06609 HKSE:02170 HKSE:01696 HKSE:06118 HKSE:02160 HKSE:01612 HKSE:02393 ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
Lane 3399, Kangxin Road, Building 15, Pudong New Area, Shanghai, CHN, 200120
Website
https://www.cryofocus.com
Cryofocus Medtech (Shanghai) Co Ltd is a medical device company engaged in the research and development, manufacture, and sale of cryoablation minimally invasive interventional treatment technology and related medical products. The company uses liquid nitrogen as the main cryogenic source for cryotherapy systems by leveraging liquid nitrogen cryoablation technology and flexible catheter technology. The products offered by the company include: Bladder Cryoablation System, Pulmonary Nodule Localization Needle, and Endoscopic Clip for Anastomosis, among others. Geographically, the company's revenue is generated from the sale of medical consumables and devices in the Chinese Mainland.
Executives
Zhuhai Junheng Investment L.p. (limited Partnership) 2101 Beneficial owner
Shang Hai Shi Di Sheng Wu Ke Ji You Xian Gong Si
Lv Shiwen 2103 Interests held jointly with another person
Shenzhen Gao Ling Tiancheng Iii Investment Co., Ltd. 2201 Interest of corporation controlled by you
Ning Bo Lin Feng Sheng Wu Ke Ji You Xian Gong Si
Wu Jianhui 2101 Beneficial owner
Li Hui 2202 Interest of your spouse
Shang Hai Shi Di Shi Ye Fa Zhan You Xian Gong Si
Sun Xiaolu 2201 Interest of corporation controlled by you
Fu Guo Ji Jin Guan Li You Xian Gong Si 2102 Investment manager
Hang Zhou Bi Lin Xing Chuang Xin Tou Zi He Huo Qi Ye You Xian He Huo
Shang Hai Bi Lin Xing Zi Chan Guan Li You Xian Gong Si
Hang Zhou Bi Lin Xing Chuang Xin Tou Zi Guan Li He Huo Qi Ye You Xian He Huo
Sheng Shan Zi Chan Guan Li Shang Hai You Xian Gong Si
Gan Shi Xiong

Cryofocus Medtech (Shanghai) Co Headlines

No Headlines